MedTrace Logo

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

NCT03086252 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-26

No results posted yet for this study

Summary

This pilot study evaluates safety of administration of red blood cell transfusions requested by patients based on their symptoms instead of levels of hemoglobin for the treatment of chronic anemia in patients with blood disorders.

Conditions

Interventions

PROCEDURE

Red Blood Cell Transfusions (RBCT)

Undergo patient-driven RBCT

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Ana Antun, MD · Emory University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-24
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03086252 on ClinicalTrials.gov